Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface
Jinghe Huang(Fudan University), Mark Connors(National Institute of Allergy and Infectious Diseases), Jeong Hyun Lee(Scripps Research Institute), James Μ. Binley(San Diego Biomedical Research Institute), Hiromi Imamichi(National Institutes of Health), Marie Pancera(Fred Hutch Cancer Center), Richard T. Wyatt(Scripps Research Institute), Stephen A. Migueles(National Institute of Allergy and Infectious Diseases), Pavel Pugach(Cornell University), Peter D. Kwong(National Institutes of Health), Barton F. Haynes(Duke University), Ronald Derking(Amsterdam UMC Location University of Amsterdam), Aliaksandr Druz(National Institutes of Health), Alba Torrents de la Peña(Scripps Research Institute), Leo Laub(National Institutes of Health), Byong H. Kang(National Institute of Allergy and Infectious Diseases), Andrew B. Ward(Scripps Research Institute), Gwo‐Yu Chuang(Moderna Therapeutics (United States)), Tommy Tong(Torrey Pines Institute For Molecular Studies), Robert T. Bailer(National Institutes of Health), John R. Mascola(National Institute of Allergy and Infectious Diseases), Ivelin S. Georgiev(Vanderbilt University), Nicole A. Doria‐Rose(National Institutes of Health), Rogier W. Sanders(Scripps Research Institute), Yu Feng(National Institutes of Health), Per-Johan Klasse(Cornell University), Kwinten Sliepen(Amsterdam University Medical Centers), Munir Alam(Duke University), Marit J. van Gils(Amsterdam University Medical Centers)
Cited by 437
Related Papers
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
|Science|1984|3.6k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
HIV preferentially infects HIV-specific CD4+ T cells
|Nature|2002|1.3k